Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer

Publikation

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer

Wissenschaftlicher Artikel/Review - 16.08.2019

Buechler Steven A, Badve Sunil S, Leyland-Jones Brian, Viale Giuseppe, Kammler Rosita, Thürlimann Beat, Willis Scooter, Gökmen-Polar Yesim, Gray Kathryn P, Regan Meredith M

Buechler, Steven A

Gray, Kathryn P

Gökmen-Polar, Yesim

Willis, Scooter

Thürlimann, Beat

259

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive, Early Breast Cancer

Buechler, Steven A

Gray, Kathryn P

Gökmen-Polar, Yesim

Willis, Scooter

Thürlimann, Beat

Kammler, Rosita

Viale, Giuseppe

Leyland-Jones, Brian

Badve, Sunil S

Regan, Meredith M